These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 27316325)
1. Impact of genetic variations in C-C chemokine receptors and ligands on infectious diseases. Qidwai T; Khan MY Hum Immunol; 2016 Oct; 77(10):961-971. PubMed ID: 27316325 [TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in CCL2&CCL5 chemokines/chemokine receptors genes and their association with diseases. Navratilova Z Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Nov; 150(2):191-204. PubMed ID: 17426779 [TBL] [Abstract][Full Text] [Related]
3. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection. Li H; Liu TJ; Hong ZH Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis. Ahad MA; Missotten T; Abdallah A; Lympany PA; Lightman S Mol Vis; 2007 Mar; 13():388-96. PubMed ID: 17417600 [TBL] [Abstract][Full Text] [Related]
5. [Association of chemokines and their receptors genes polymorphisms with risk of myocardial infarction]. Xu X; Wang LH; Liu HB; Xu CF; Zhang P; Yong F; Shi YP Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):601-7. PubMed ID: 24078580 [TBL] [Abstract][Full Text] [Related]
6. Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease. Huerta C; Alvarez V; Mata IF; Coto E; Ribacoba R; Martínez C; Blázquez M; Guisasola LM; Salvador C; Lahoz CH; Peña J Neurosci Lett; 2004 Nov; 370(2-3):151-4. PubMed ID: 15488313 [TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of CCL2, CCL5, CCR2 and CCR5 genes in Sahariya tribe of North Central India: an association study with pulmonary tuberculosis. Mishra G; Poojary SS; Raj P; Tiwari PK Infect Genet Evol; 2012 Jul; 12(5):1120-7. PubMed ID: 22554651 [TBL] [Abstract][Full Text] [Related]
8. RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population. Cheong JY; Cho SW; Choi JY; Lee JA; Kim MH; Lee JE; Hahm KB; Kim JH J Korean Med Sci; 2007 Jun; 22(3):529-35. PubMed ID: 17596666 [TBL] [Abstract][Full Text] [Related]
9. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study. Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295 [TBL] [Abstract][Full Text] [Related]
10. High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients. Yeregui E; Viladés C; Domingo P; Ceausu A; Pacheco YM; Veloso S; Inciarte A; Vidal-González J; Peraire M; Perpiñán C; Falcó V; Masip J; Alba V; Vargas M; Martí A; Reverté L; Mallolas J; Vidal F; Peraire J; Rull A EBioMedicine; 2020 Dec; 62():103077. PubMed ID: 33166788 [TBL] [Abstract][Full Text] [Related]
11. Significance of CCL2, CCL5 and CCR2 polymorphisms for adverse prognosis of Japanese encephalitis from an endemic population of India. Chowdhury P; Khan SA Sci Rep; 2017 Oct; 7(1):13716. PubMed ID: 29057937 [TBL] [Abstract][Full Text] [Related]
12. Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia. Pang Y; Li H; Gong Y; Jing S; Peng C; Liu W; Zhao Y; Wang H; Kaushik D; Rodriguez R; Wang Z Oncol Rep; 2019 Apr; 41(4):2491-2501. PubMed ID: 30816510 [TBL] [Abstract][Full Text] [Related]
13. Association between the Genetic Polymorphisms of Shao LN; Zhou SH; Wang N; Zhang ST; Liu M Immunol Invest; 2022 Jul; 51(5):1182-1197. PubMed ID: 33902378 [TBL] [Abstract][Full Text] [Related]
14. Chemokine genetic polymorphism in human health and disease. Qidwai T Immunol Lett; 2016 Aug; 176():128-38. PubMed ID: 27262929 [TBL] [Abstract][Full Text] [Related]
15. Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders. Fantuzzi L; Tagliamonte M; Gauzzi MC; Lopalco L Cell Mol Life Sci; 2019 Dec; 76(24):4869-4886. PubMed ID: 31377844 [TBL] [Abstract][Full Text] [Related]
16. CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan. Konishi I; Horiike N; Hiasa Y; Michitaka K; Onji M Intervirology; 2004; 47(2):114-20. PubMed ID: 15192276 [TBL] [Abstract][Full Text] [Related]
17. Genetic variants in the chemokines and chemokine receptors in Chagas disease. Flórez O; Martín J; González CI Hum Immunol; 2012 Aug; 73(8):852-8. PubMed ID: 22537745 [TBL] [Abstract][Full Text] [Related]
18. Chemokine MCP1/CCL2 and RANTES/CCL5 gene polymorphisms influence Henoch-Schönlein purpura susceptibility and severity. Yu HH; Liu PH; Yang YH; Lee JH; Wang LC; Chen WJ; Chiang BL J Formos Med Assoc; 2015 Apr; 114(4):347-52. PubMed ID: 25839768 [TBL] [Abstract][Full Text] [Related]
19. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer. Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413 [TBL] [Abstract][Full Text] [Related]
20. MCP-1, CCR2 and CCR5 polymorphisms in Tunisian patients with atopic asthma. Dhaouadi T; Sfar I; Aounallah-Skhiri H; Jendoubi-Ayed S; Bouacha H; Ben Abdallah T; Gorgi Y Iran J Allergy Asthma Immunol; 2013 Mar; 12(1):29-36. PubMed ID: 23454776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]